Want to see JP:7813 full AI Analyst Report?
Top Page
PLATZ Co., Ltd.
(7813)
Select Model
Select Model
Rating:59Neutral
Price Target:
¥845.00
▲(0.72% Upside)
Action:Reiterated
Date:08/17/26
The score is driven primarily by moderate financial performance (earnings recovery and improving leverage, but uneven revenue and historically volatile cash flow). Technical indicators are a meaningful headwind (bearish momentum and below key moving averages). Valuation is a relative positive, with a moderate P/E and a near-3% dividend yield providing support.
Positive Factors
Earnings Recovery
Net income rose from ¥65.7M in 2024 to ¥235.5M in 2026, showing a meaningful recovery from the trough. If sustained, this improves internal funding capacity and supports customer, product, and operating investment, although absolute profitability remains moderate.
Negative Factors
Uneven Revenue Growth
Revenue slipped in 2026 after a surge in 2025, and the reported growth rate is -1.52%. This uneven demand pattern makes planning and capacity utilization less predictable, limiting confidence that recent earnings recovery reflects a durable expansion in hospital and care-equipment sales.
Read all positive and negative factors
Positive Factors
Negative Factors
Earnings Recovery
Net income rose from ¥65.7M in 2024 to ¥235.5M in 2026, showing a meaningful recovery from the trough. If sustained, this improves internal funding capacity and supports customer, product, and operating investment, although absolute profitability remains moderate.
Read all positive factors
PLATZ Co., Ltd. (7813) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.09B
Dividend Yield2.73%
Average Volume (3M)4.70K
Price to Earnings (P/E)12.6
Beta (1Y)0.25
Revenue Growth-1.52%
EPS Growth27.39%
CountryJP
Employees149
SectorGeneral
Sector StrengthN/A
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)69.64
Shares Outstanding3,726,000
10 Day Avg. Volume4,840
30 Day Avg. Volume4,703
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)0.89
Price to Sales (P/S)0.36
P/FCF Ratio14.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PLATZ Co., Ltd. Business Overview & Revenue Model
Company Description
PLATZ Co., Ltd. (7813) is a Japanese company primarily engaged in the planning, development, and sale of medical and nursing-care related equipment, with a focus on hospital and care-facility beds and associated products and services for healthcar...
How the Company Makes Money
PLATZ generates revenue mainly through the sale of medical and nursing-care equipment, particularly hospital and care beds, to institutional customers such as hospitals, nursing-care facilities, and related distributors. Revenue is typically recog...
PLATZ Co., Ltd. Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
66
Positive
Cash Flow
52
Neutral
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.29B | 8.42B | 6.39B | 6.31B | 6.38B |
| Gross Profit | 2.68B | 2.52B | 1.90B | 1.80B | 2.17B |
| EBITDA | 412.03M | 323.51M | 106.28M | -42.44M | 160.84M |
| Net Income | 235.47M | 192.98M | 65.67M | 222.38M | 263.60M |
Balance Sheet | |||||
| Total Assets | 6.45B | 6.25B | 6.27B | 6.03B | 6.48B |
| Cash, Cash Equivalents and Short-Term Investments | 1.58B | 1.73B | 2.06B | 2.00B | 1.46B |
| Total Debt | 2.06B | 2.13B | 2.10B | 2.25B | 2.37B |
| Total Liabilities | 3.07B | 3.15B | 3.08B | 2.89B | 3.51B |
| Stockholders Equity | 3.39B | 3.10B | 3.19B | 3.14B | 2.97B |
Cash Flow | |||||
| Free Cash Flow | 204.42M | 3.98M | 366.06M | 358.92M | -287.74M |
| Operating Cash Flow | 286.50M | 218.96M | 392.38M | 417.26M | -103.43M |
| Investing Cash Flow | -255.18M | -400.77M | 141.08M | 290.05M | -142.64M |
| Financing Cash Flow | -184.95M | -147.01M | -478.10M | -161.58M | 151.76M |
PLATZ Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥63.47B | 15.82 | ― | 3.22% | 13.57% | 0.34% | |
72 Outperform | ¥82.68B | 13.45 | ― | 2.83% | 6.53% | 52.32% | |
67 Neutral | ¥144.94B | 16.96 | 24.90% | 1.53% | 15.46% | 6.44% | |
62 Neutral | ¥142.36B | 19.99 | 6.57% | 1.78% | 5.05% | 50.43% | |
59 Neutral | ¥3.09B | 12.61 | ― | 2.21% | -1.52% | 27.39% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ¥19.22B | 20.42 | ― | 2.65% | 2.22% | -2.17% |
* General Sector Average
JP:7813
PLATZ Co., Ltd.
878.00
129.42
17.29%
JP:3046
JINS HOLDINGS
6,020.00
-1,791.62
-22.94%
JP:7780
Menicon Co
1,926.00
738.95
62.25%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,666.00
654.56
32.54%
JP:7743
Seed Co., Ltd.
735.00
199.18
37.17%
JP:7979
Shofu Inc.
2,335.00
427.94
22.44%
PLATZ Co., Ltd. Corporate Events
PLATZ Boosts Profitability and Strengthens Balance Sheet Despite Slight Sales Decline
Aug 7, 2026
PLATZ Co., Ltd. reported consolidated net sales of ¥8.29 billion for the fiscal year ended June 30, 2026, a slight 1.5% decline from the prior year, while significantly improving profitability. Operating profit jumped 38.1% to ¥253 milli...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.